Suchbegriffe: LITHIUM - THERAPEUTIC USE , . Treffer: 4
Bengesser, SA; Reininghaus, EZ; Lackner, N; Birner, A; Fellendorf, FT; Platzer, M; Kainzbauer, N; Tropper, B; Hörmanseder, C; Queissner, R; Kapfhammer, HP; Wallner-Liebmann, SJ; Fuchs, R; Petek, E; Windpassinger, C; Schnalzenberger, M; Reininghaus, B; Evert, B; Waha, A
Is the molecular clock ticking differently in bipolar disorder? Methylation analysis of the clock gene ARNTL.
World J Biol Psychiatry. 2018; 19(sup2):S21-S29
Doi: 10.1080/15622975.2016.1231421
Web of Science
PubMed
FullText
FullText_MUG
Consortium on Lithium Genetics; Hou, L; Heilbronner, U; Rietschel, M; Kato, T; Kuo, PH; McMahon, FJ; Schulze, TG
Variant GADL1 and response to lithium in bipolar I disorder.
N Engl J Med. 2014; 370(19):1857-1859
Doi: 10.1056/NEJMc1401817#SA4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Iaizzo, PA; Quasthoff, S; Lehmann-Horn, F
Differential diagnosis of periodic paralysis aided by in vitro myography.
Neuromuscul Disord. 1995; 5(2):115-124
Doi: 10.1016/0960-8966(94)00036-9
Web of Science
PubMed
FullText
FullText_MUG
Lahousen, M; Pickel, H; Haas, J
Lithium carbonate--a preventive agent against leukopenia during cytostatic therapy
Wien Klin Wochenschr. 1984; 96(19):739-741
Web of Science
PubMed
Google Scholar